Loading insider details...
Beta
Latest Form 4 (Jul 9, 2026): Grant/Award of 6,800 CRIS shares, $36.0K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jul 9, 2026 | CURIS INC (CRIS) | Grant/Award | 6,800 | $36.0K |
| Jun 23, 2026 | ArriVent BioPharma, Inc. (AVBP) | Grant/Award | 13,562 | n/a |
| Jun 20, 2025 | ArriVent BioPharma, Inc. (AVBP) | Grant/Award | 15,502 | n/a |
| May 22, 2025 | CURIS INC (CRIS) | Grant/Award | 14,400 | $45.1K |
| Jan 30, 2025 | CURIS INC (CRIS) | Grant/Award | 1,600 | $5.0K |
| Jun 27, 2024 | Carisma Therapeutics Inc. (CARM) | Grant/Award | 19,350 | n/a |
| May 23, 2024 | CURIS INC (CRIS) | Grant/Award | 4,250 | $49.4K |
| May 20, 2024 | ArriVent BioPharma, Inc. (AVBP) | Grant/Award | 29,550 | n/a |
| Apr 1, 2024 | Carisma Therapeutics Inc. (CARM) | Grant/Award | 38,700 | n/a |
| Jun 12, 2023 | Evelo Biosciences, Inc. (EVLO) | Grant/Award | 20,000 | n/a |